Cerebral Vascular Effects of a New Derivative of 1, 4-Dihydropyridine (YC-93), with Special Reference to Its Effect on the Experimental Basilar Artery Spasm in Cats by 半田, 譲二
Title1, 4-Dihydropyridine誘導体YC-93の脳血管に対する作用 :ネコ脳底動脈の実験的収縮に対する拮抗作用を中心に
Author(s)半田, 譲二




Type Departmental Bulletin Paper
Textversionpublisher
Kyoto University







Cerebral Vascular Effects of a New Derivative of 
1,4-Dihydropyridine (YC-93), with Special Reference 
to Its Effect on the Experimental Basilar Artery 
Spasm in Cats 
by 
]YOJI RANDA 
Department of Neurosurgery, Kyoto University '.¥ledical School 
and Hospital, Kyoto, Japan 
YC-93, a new derivative of 1, 4-dihydropyridine (Fig. 6 ), has been reported to have 
potent dilator action on the cerebral vessels in experimental animals such as the cat, dog, 
and monkey. The effect has been proved to be dose-dependent, and on the basis of dosage 
per kilogram body weight, much more potent than that of papaverine hydrochloride by a 
factor of 100 to 300. 
In man, 133Xenon clearance study showed that an intravenous administration of 1 
microgram/kg of YC・93increased the cerebral blood flow by approximately 5 per cent, and 
with 10 microgram/kg dosage, the increase in the cerebral blood flow amounted well to 13 
per cent (n=8, pく0.01) with minimal decrease in the systemic arterial pressure (n=8, n.s.) 
and no charge in PaC02 ( n=7 ). 
A topical application of 0. 001 to 0.1 mg/ml of YC-93 to the surgically exposed basilar 
artery in the cat showed a marked increase in the caliber of the artery. Experimental basilar 
artery constriction (spasm〕witha topical application of prostaglandin E2, prostaglandin F2刊，
serotonin, or fresh autologous blood, was promptly reversed by an application of 0. 01 mg. ’ml 
solution of YC-93. Once treated with this concentration of YC-93, the basilar artery remained 
refractory to the repeat application of serotonin, prostaglandins, or fresh blood. In addition, 
the treated artery failed to show any reactive constriction to the mechanical stimuli to the 
arterial wall. 
Key Words: Cerebral blood flow, cerebral vasodilator, cerebral vasospasm, YC-93, 1,4-dihydropyridine 
derivative 
Present address: Department of Neurosurgery, Kyoto University '.¥ledical School and Hospital, Sakyo・ku
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During craniotomy in six clinical cases, th巴int巴rnalcarotid art巴ryor the middle cerebral 
artery showed a marked spasm, seemingly due to the mechanical stimuli. This was reversed 
comp let巴lyand promptly by an application of the cottonoid pledget soaked in 0. 001 to O. 01 
mg1 ml solution of YC 93 to the constricted segment of the artery. :¥o postoperative 








phenyl)-1,4-dihydropydridine 3,5 dicarboxylic acid 
3 {:2-(n-benzyl-n methylamino）トethylester 5-me-










































い流した直後， 1,'.!, 3, 4, 5, 10, 15, 20, 30分後，
にそれぞれ写真撮影を行なった．








lζ，0. 001, 0. 01, 0. lmg 'mlの各濃度のYC-93溶液
0.2～0.3mlを5分間接触させ， 接触前，接触開始後






0. OOlmg/mlの YC-93溶液の接触では， 4匹とも
軽度の動脈拡張を示し，動脈直径の増大は約10匂粍度











0. Olmg,1ml 溶液を接触させる と， 動脈は極度lζ拡張
しその壁は奔薄化し，さらlζ脳表の細小血管にもつ
よい拡張がみられた． 0. Olmg ml溶液の接触ですで














縮と， ζれに対する YC-93の拾抗作用（7匹〕 （表
I，図1. 2) 
Heparin加新鮮自家動脈血を5分間脳底動脈 lこ直
接接触させると， 脳底動脈直径は 0.492mm(±O. 118〕










より有意に大となり （p< 0. 05), 2分後lζは 0.492
mm (±0. 075）と新鮮自家血接触前lζ等しく，その後
も増大を続けて30分後には 0.744mm (±0. 103）に達
した Cp<O.005). 
ζの実験終了後3M）＇を筏過してのち，脳底動脈がな
お拡張を示しているH寺点で f0. 732mm (±0.109）； ふ
3’ 5’ 20' 
Fig. 1 To show the effect of河 topicaladministration of 、仁－93on the blood induced 、・a叫 JCOI】strictionof feline basilar artery. Upp,,. co/1111 Control, Lou•ci column 
YC 93 treatment after production of vasoconstnction 
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Table 1. Effect of topical application of YC-93 on blood-induced basilar arterぅ const口ction
m cat. p・＝statisticalsignificance compared with corresponding value in studv I 
Minutes after 
Study I Control' N('. ｜。 2 3 4 5 10 15 20 30 
Mean .492 .336 .336 .336 .348 .372 .384 .420 .456 .468 .468 
S. D. .118 .063 .062 目062 .078 .091 .070 .102 .093 .086 目083
Mean .492 .341 .420 .492 .557 .637 .673 .711 7-19 .752 .7-l.! 
l S. D. .103 .065 .059 .075 .091 .111 .127 .236 .114 .105 .103 
p ネ n. s. n. s. p<0.05 < - p<0.005 一ー一一今
λlean .732 .680 .696 .716 .720 7ー26 .750 752 .745 745 714 
皿 S. D .109 .135 .139 .130 .123 .126 .120 .118 .122 .122 .133 
p キ ぐ一一一一 p<0.005 一ー一→
Mean 7:30 .653 .663 .666 .666 .680 .692 742 .720 744 .730 
I¥ S.D. .i39 .178 .177 .183 目171 .164 .173 .133 .146 .142 .134 
p 本 令一一一一一 pくり005 一ー一一歩
mm 
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Fig. 2 To show the effect of a topical admini-
stration of YC-93 on the blood-induced 
vasoconstrictiυn of feline basilar arterv 
Magnification x2 and photographic enlar 
gement. 1 Control. 2 YC-93 treatment 























大の傾向を示したが， 30・.11主にもなお 0.385mm (± 
0.097）と，対照値には復しえなかった．
初回 PGFc,f生l針変60＇，｝を任 i位して脳底動脈直径が
0. 414mm (±0. 097）とほぼ旧IC復したとき， ふたた
ぴ同濃度の PGF2α を5分間接触させると，脳底動脈
直径は 0.268mm (±0. 074〕にまで減少し、との動脈
~ ~＼ri＼の f'f度は第 1 回のそれに比し統計学的に有意の差
をみとめなかった しかし，ととで PGFe.，を洗献し
て 0Olmg 1mlの YC-93溶液を5分間接触させる
と，脳底動脈の収縮は，＇.，： 1_,!Jiに回復し， 3分後lζは動脈
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Table 2. Effect of topical application of YC-93 on PGF "n-induced basilar artery constrict10n 
in cat. pホ＝statisticalsignificance compared with corresponding、aluein study I. 
Study I c…I! :v11nute邑 after一一一一 司No. 。 1 2 3 4 :> 10 15 20 30 
一 一 一
Mean .427 .280 .298 .313 .321 .321 .337 .3-+2 .348 .369 .385 
S. D. .111 .056 .061 .051 .042 .051 .050 .041 .044 .060 .097 
Mean , .414 .268 .336 .367 .412 .453 .493 .645 .664 .663 .697 
I S. D. .097 .074 .071 .061 .055 .074 .060 .088 .092 .103 .107 
p ホ n. s. n s n s. n. "・ 〈 一ー－ p/() 005 
Mean .727 .718 .730 .736 .745 .736 .735 .7－＋~ .739 .727 .730 
皿 : S. D. .136 .135 .126 .132 .128 .146 .141 .12.5 .134 .151 .127 
p* 争ー一 p<0.005 一一→
Mean .712 .676 .681 .687 .690 .684 .700 .7()3 .694 .697 .699 
IV I s. D. .147 .122 .115 .125 .120 .132 .119 .131 .135 .108 .113 
p* 今ー一 p<0.005 ーー今
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TOPICAi.. PGY .. ち備前回・・・ームー－TIMε 。
Fig. 3 To show the effect of a topical adm mト
stration of YC-93 on the prostaglandin 
F 2a-rnduced vasoconstriction of feline 
basilar artery. 1: Control, 2: YC-93 
treatment after production of vasocon-
striction. 3 and 4: topical application of 
prostaglandin F 2αon the basilar arter) 
pretreated with YC-93. 












PGE2 20 micrograms・ ’ml溶液を直接脳底動脈lζ接
触させると，脳底動脈は 0.479mm （土0.054）から





の PGE2溶液を接触させると，動脈直径は 0.492mm 
(±0. 058）から 0.315mm （二0.0-15）へ減少し， ζの
動脈収縮の程度は初回のそれに比し差がなかった．し
かし， PGE2溶液洗機後，5分間にわたり 0.Olmg/ml 
の YC-93溶液を接触させると，動脈は急速に拡張L.
I分自にはすでに 0.454mm (±0. 117；と初回の同時
点での直径より有意に大きく （0.01くp<O.02), 2分
自には原直径を越えて0.54lmm(±O. lOl)Cp<O. 005) 
lζ達し，その後も拡張をつづ！ナて 30分後には 0.729 
mm （土0.089) Iζ達した．
さらに30分後，脳底動脈がなお拡張を示している段
階で重ねて PGE220 micrograms ml 溶液を局所に投
与しでも，動脈直径はほとんど変化しなかった10.727 




て 20micrograms/mlの PGE2溶液を 5分間接触さ
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Table 3. Effect of topical application of YC 93 on PGErinduced basilar artery constriction 










仁川oli 。 1 2 
:¥lean .179 .311 .327 .367 
S. D. I .054 .047 .051 .061 
'.¥lean .192 .315 -<154 .541 
S D .058 .045 .117 .101 
p* n. s. n. s. 0.01くp 〈一一ー一
Mean 1 
<0.02 
，ー27 .717 .715 .729 
S. D. .084 .105 .095 .086 
p 本 会一一 pく0.005
'.¥lean .723 .713 .706 .708 
S. D. .091 099 .103 .098 
p* 舎一一 p<0.005 
EFFECT OF TOPICAL YC・93ON 
PGE,-INDUCED VASOCONSTRICTION 
3 
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Fig. 4 To show the effect of a topical admini-
stration of YC-93 on the prostaglandin 
E2-rnduced、asoconstriction of feline 
basilar arterv 1 ・ Control, 2 YC-93 
treatment after production of vasocon-
striction, 3 and 4・topicalapplication of 
prostaglandin E2 on the basilミrart er、
pretreated with YC-93 
¥linutes after 
3 4 5 10 15 20 30 
.385 400 .423 .431 .450 .458 .483 
.065 .069 .079 .062 .057 .066 .050 
.577 .610 .633 .685 .706 .721 .729 
.104 .111 .096 .087 .095 .090 .089 
p<0.005 一ー歩
.729 .723 .731 .731 .735 .733 .731 
.085 .091 .081 .091 .093 .084 .094 
一ー今
.708 .704 .706 .709 .706 .700 .702 




mm (±0. 04めから 0.306 (±0. 045〕へと著明iζ減少
した．その後5-HT溶液を洗い流して継時的lζ測定す
ると，脳底動脈直径は徐々に増大の傾向を示したが，










lζは 0.377mm (±0. 056）とすでに対照実験における
直径より有意IC大となり（pく0.05), 30分自には0.662 
mm (±0. 047) Iこまで達した．2分目以後の直径は対
照実験におけるそれに比し，高度の有意性をもって大
せたが，動脈直径は［まとんど不変であった〔0.713mm であった（p<0.005〕
(±0. 099) さらに30勺後、脳底動脈直径が 0.668mm(±O. 041) 
以上から， ζの濃度の PEG2はつよい脳底動脈収縮 と明らかな増加を示している状態で，同じ濃度のふ
をきたすが， O.Olmg_mlのYC-93溶液の接触は PGE2 HT溶液を5分間接触させたが，動脈収縮はみとめら
による動脈収縮の回復過T'Eを著明iζ促進させ，原直径 れなかった．
を越えてむしろ拡張した脳底動脈lζくりかえし PGら さらに30分後もう 1度 5-HTの局所投与を試みた
を接触させても，明らかな動脈収縮はすくなくと も90 が， ゃ：まり脳底動脈の明らかな収縮をみとめるととは
分間にわたりみとめられなくなる，といえる． できなかった．
第1群 5-HTによる脳底動脈収縮と， ζれに対す 以上より， 0.01mg mlの YC-93溶液の局所投与
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Table 4. Effect of topical application of YC-93 on 5-HT-induced basilar artery constriction 




No 。 1 2 3 4 5 10 15 20 30 
.454 .306 .321 .349 .360 .377 .379 .411 .401 .441 .413 
S. D. .045 .045 .039 .033 .032 .042 .047 .039 .063 .045 .052 
Mean .431 .277 .377 .443 .495 .561 .591 .619 .fi'.?f) .643 .662 
I I S.D .063 .056 .056 .044 .022 .039 .039 .032 .058 .047 .047 
ll0;:)0 n. s. pく0.05 ＜－ーー pく0.005 ーー一今
Mean .668 .656 .660 .662 .660 .664 .662 .662 .669 .673 .668 
皿 I S. D. .041 .047 .049 .042 .047 .053 .053 .052 .041 .043 .043 
p キ 舎一一 p<0.005 一一一一 一ー一→
お1ean .654 636 .643 .649 .651 .651 .647 .639 .619 .626 .628 
N S. D. .057 .076 .059 .065 .066 .065 .065 .072 .095 .076 .079 
p 本 そ一一 p<0.005 ーー一歩
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Fig. 5 To show the effect of a topical admini-
stration of YC 93 on the serotonin守induced
vasoconstriction of feline basilar artery 
1: Control, 2 YC-93 treatment after 

















































で， lkiζよく 浴：ナる黄色の結晶性粉末である． その
LDsoは，静脈内投与でマウス 20.7mg ・kg（古）， 19.9 
mg/kg（♀〉，ラ yト15.5mg/kg（早）， 17. 2mg/kg（平），
イヌ 6.lmg/kg，また経口投与では7 ワス 634mg/kg 






3, 5.dicarb。xyl1c acid 3・J2.(N-benzyl・N-methylamin。l-
ethyl ester 5・methylester hydrochloride (YC-93) 

























傾向を示し（約5%). また 0.01 mg1kgの投与では
12°;' (31. 6→ 36. 8ml/min"l00g, p<O. 01, n= 8, 

















































































触させると，脳底動脈はそf明な拡張を示す. 0. Olmg/ 
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